Remedy
Summary active Updated Jun 14, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
Remedy (also known as Remedy Science) is a dermatologist-developed skincare brand founded in 2024 by Dr. Muneeb Shah, a board-certified dermatologist with a large social media following 12. The company sells clinically tested products targeting concerns including dark spots, dryness, fine lines, dullness, keratosis pilaris, and sensitive skin, distributed through DTC, Amazon, and Target 12. As of the Series A announcement, investors said Remedy had been profitable since year one and was on track to hit $50 million in sales in 2026 2.
Profile is a stub based on the round announcement. Sections below will expand as additional sourced information is verified.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-06-11 | Series A | $20M | L Catterton | Norwest Venture Partners, Sonoma Brands Capital 123 |
What Investors Say
No independently sourced investor commentary captured at profile creation.
What Founders Say
No independently sourced founder testimonials captured at profile creation.
Sources
-
BusinessWire, “REMEDY Raises Series A Led by L Catterton to Modernize Dermatologist-Developed Skincare,” June 11, 2026, accessed June 2026. https://www.businesswire.com/news/home/20260611875114/en/REMEDY-Raises-Series-A-Led-by-L-Catterton-to-Modernize-Dermatologist-Developed-Skincare↩↩↩
-
BeautyMatter, “Dr. Muneeb Shah’s Remedy Closes $20 Million Series A,” June 2026, accessed June 2026. https://beautymatter.com/articles/dr-muneeb-shahs-remedy-closes-20-million-series-a↩↩↩↩
-
Beauty Independent, “Dr. Muneeb Shah’s Remedy Raises $20M Series A Round As Investors Double Down On Clinical Skincare,” June 2026, accessed June 2026. https://www.beautyindependent.com/dr-muneeb-shah-remedy-20m-series-a-round-investors-clinical-skincare/↩